ReviewAsia-Pacific journal of oncology nursing2026
Development and preliminary validation of a PICC-related venous thrombosis risk prediction model for cancer patients: A systematic review and meta-analysis predominantly based on Chinese populations.
Review in Asia-Pacific journal of oncology nursing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify key risk factors for peripherally inserted central catheter -related deep venous thrombosis (PICC-RVT) in patients with cancer through a systematic review and meta-analysis, develop risk prediction model and validate its performance. Methods: A systematic literature search was performed in Pubmed, EMBASE, Web of Science (core collection), Scopus, CINAHL and Ovid databases from the time of their inception to June 2025. Study quality was assessed using the Newcastle-Ottawa Scale (NOS) checklist. Meta-analysis was performed using RevMan 5.4 statistical software to identify independent risk factors for PICC-RVT in adult patients with cancer, then the effect of each independent risk factor was determined using Results: A total of 32 cohort studies involving 28,813 individuals (28 from China, 2 from UK, 1 each from US and Canada) were included. Twenty-one independent risk factors were identified through meta-analysis. The risk prediction model was developed using Conclusions: This study developed a PICC-RVT risk prediction model based primarily on Chinese patients with cancer. The model demonstrated moderate discrimination in preliminary single-center validation, but requires multi-center validation with adequate event numbers before clinical implementation. The model provides a framework for PICC-RVT risk stratification in Chinese and similar healthcare settings. Systematic review registration: PROSPERO (CRD420250651190).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.